Cambridge Healthtech Institute’s 9th Annual
Emerging Targets for Oncology & Beyond
Hitting the Targets
12 November 2025
Cambridge Healthtech Institute's 9th Annual Emerging Targets for Oncology & Beyond conference will cover a range of topics including innovative approaches for target discovery, emerging target landscapes for oncology, and expanding into other indications including auto-immune/inflammatory diseases, metabolic, and CNS disorders. This year’s conference will spotlight how new technologies are changing the way targets are discovered, validated and delivered. By bringing together leading researchers in the field, the event seeks to uncover new targets and pioneer novel approaches to repurpose established targets for other indications.
Coverage will include, but is not limited to:
Innovative Approaches for Target Discovery
- Future of target discovery—how will new technologies change the way targets are discovered?
- Understanding, accounting for, and harnessing target heterogeneity
- AI-powered target discovery
- Immunopeptidomics
- Spatial Transcriptomics
Emerging Targets for Oncology
- B7H3, DLL3, GPC3, PRAME, MICA/B, IGSF8, TROP-2, B7H6, B7H7, TLR
- Novel tumour antigens and their validation
- Targeting the innate immune system
- Combination therapies and dual-targeting approaches
Novel Targets and Approaches for Autoimmune/Inflammatory Diseases
- TL1A
- Targeting surface membrane proteins
- Developing companion biomarkers
Diabetes and Obesity Therapeutic Targets
Repurposing Old Targets for New Indications
- GPC, HER2, CEA, Folate Receptor, KRAS, CD47
- Combination therapies for new indications
The deadline for priority consideration is 28 March 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: